Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 3,500
- Avg volume
- —
- Day's range
- $0.40 – $0.45
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
TempraMed Technologies Ltd., a medical device technology company, develops patent-protected technology designed to serve a broad range of medical and consumer products. Its primary focus is storage and management of injectable for temperature-sensitive medications. The company provides VIVI Cap, an insulin insulation and travel case; VIVI Cap Smart, a connected insulin storage and protection; VIVI Med, a temperature...
Show more
TempraMed Technologies Ltd., a medical device technology company, develops patent-protected technology designed to serve a broad range of medical and consumer products. Its primary focus is storage and management of injectable for temperature-sensitive medications. The company provides VIVI Cap, an insulin insulation and travel case; VIVI Cap Smart, a connected insulin storage and protection; VIVI Med, a temperature medication; and VIVI Epi, a Storage and Protection for EpiPen. The company was incorporated in 2023 and is based in Burnaby, Canada.
- Industry
- Medical Devices
- Sector
- Healthcare
- Website
- https://tempramed.com
- Address
- 501-3292, Production Way, Burnaby, Canada
Latest news
No headlines yet.
